Stoke Therapeutics
STOK
STOK
88 hedge funds and large institutions have $1.16B invested in Stoke Therapeutics in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.8% less ownership
Funds ownership: 105.99% → 104.19% (-1.8%)
43% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 28
Holders
88
Holding in Top 10
2
Calls
$1.48M
Puts
–
Top Buyers
| 1 | +$39.2M | |
| 2 | +$2.23M | |
| 3 | +$1.58M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.41M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.32M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$6.06M | |
| 3 | -$5.48M | |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.66M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$2.18M |